type 2 diabetes

Eli Lilly's diabetes treatment meets main goal in two late-stage studies
Reuters
Tue, 10/2/18 - 10:54 pm
Eli Lilly
Ultra Rapid Lispro
Humalog
diabetes
type 1 diabetes
type 2 diabetes
Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront
BioSpace
Thu, 09/27/18 - 11:53 am
Eli Lilly
Chugai
OWL833
type 2 diabetes
Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes
CP Wire
Mon, 09/24/18 - 10:01 am
AstraZeneca
Farxiga
Dapagliflozin
clinical trials
type 2 diabetes
cardiovascular disease
How One Class Of Diabetes Medications May Lead To Flesh-Eating Genital Infections
Forbes
Mon, 09/3/18 - 12:02 pm
FDA
type 2 diabetes
SGLT2 inhibitor
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
BioSpace
Mon, 08/20/18 - 10:42 pm
Novo Nordisk
clinical trials
semaglutide
type 2 diabetes
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
NASDAQ.com
Tue, 06/26/18 - 09:47 am
Amgen
Repatha
type 2 diabetes
diabetes
hypercholesterolemia
ADA
How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab
Forbes
Thu, 06/7/18 - 09:48 am
ASCO 2018
lung cancer
type 2 diabetes
metformin
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Drug Delivery Business News
Fri, 03/23/18 - 09:45 am
Japan
Novo Nordisk
diabetes
type 2 diabetes
Ozempic
Novo Nordisk’s once-weekly Type II diabetes med approved in Europe
Drug Delivery Business News
Fri, 02/9/18 - 09:30 am
Novo Nordisk
diabetes
type 2 diabetes
Europe
Ozempic
Spread of diabetes in the world: state of the art
GoinPharma
Fri, 02/2/18 - 11:05 pm
type 2 diabetes
IQVIA
Novo gains FDA OK for semaglutide
BioPharma Dive
Wed, 12/6/17 - 11:48 pm
Novo Nordisk
semaglutide
FDA
Ozempic
type 2 diabetes
Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD
NASDAQ.com
Thu, 11/16/17 - 09:36 am
Jardiance
Eli Lilly
type 2 diabetes
PAD
Cost of diabetes epidemic reaches $850 billion a year
Yahoo/Reuters
Tue, 11/14/17 - 07:45 am
diabetes
type 2 diabetes
Regulus reports a trio of pipeline setbacks
BioPharma Dive
Tue, 06/13/17 - 12:00 pm
Regulus
RG-101
RGLS5040
RG-105
cholestatic disease
type 2 diabetes
hepatitis C
Johnson & Johnson's Analyst Day Was Overshadowed by This Worrisome Data
Motley Fool
Tue, 05/30/17 - 10:05 am
JNJ
Invokana
type 2 diabetes
FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug Label
RAPS.org
Tue, 05/16/17 - 10:48 pm
FDA
Janssen
type 2 diabetes
warnings
Invokana
Invokamet
Novo Nordisk launches Xultophy diabetes therapy in U.S.
Mass Device
Thu, 05/4/17 - 09:45 am
Novo Nordisk
Xultophy
diabetes
type 2 diabetes
insulin degludec
liraglutide
MannKind Hopes To Reverse Fortunes With Television Show
Seeking Alpha
Wed, 05/3/17 - 02:17 pm
MannKind
television ads
diabetes
type 2 diabetes
DTC advertising
Virta Health looks to reverse, not treat, Type II diabetes
Drug Delivery Business News
Wed, 03/8/17 - 05:36 pm
Virta Health
type 2 diabetes
diabetes
devices
patients
mobile apps
Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league competition
Endpoints
Tue, 03/7/17 - 11:55 am
Merck
Pfizer
FDA
ertugliflozin
diabetes
type 2 diabetes

Pages